Skip to main content
Research and innovation

Manifesto for EU COVID-19 Research

Ensuring that EU-funded coronavirus research results are accessible to all. View supporting organisations, download and endorse the manifesto. 

Maximising the accessibility of COVID-19 research results

The Commission launched a manifesto to maximise the accessibility of research results in the fight against COVID-19 in July 2020. The validity of the Manifesto has been extended by one year, until 1 January 2023, as it remains highly relevant in the fight against the pandemic.

The manifesto provides guiding principles for beneficiaries of EU research grants for coronavirus prevention, testing, treatment and vaccination to ensure that their research results will be accessible for all and guarantee a return on public investment.

Manifesto for EU COVID-19 Research
(270.12 KB - HTML)

Frequently asked questions

Endorse the Manifesto for EU COVID-19 Research

Endorse the manifesto

The manifesto seeks the voluntary support and endorsement from public and private stakeholders benefitting from EU funding, other research funders and prominent individuals and institutions.

Endorsing the manifesto does not entail legal implications for signed grants.

This initiative is in line with several international actions such as the COVID-19 resolution adopted by the World Health Assembly on 19 May and the Solidarity call for Action by the World Health Organisation.

By endorsing the manifesto you commit to

Make the generated results, whether tangible or intangible, public and accessible without delay, for instance on the Horizon Results Platform, on an existing IP sharing platform, or through an existing patent pool.

Make scientific papers and research data available in open access without delay and following the FAIR principles via preprint servers or public repositories, with rights for others to build upon the publications and data and with access to the tools needed for their validation.In particular, make COVID-19 research data available through the European COVID-19 Data Platform

Where possible, grant for a limited time, non-exclusive royalty free licences on the intellectual property resulting from EU-funded research. These non-exclusive royalty free licenses shall be given in exchange for the licensees’ commitment to rapidly and broadly distribute the resulting products and services under fair and reasonable conditions to prevent, diagnose, treat and contain COVID-19.


So far, more than 650 organisations (including universities, research institutes and private companies) and more than 1875 individuals endorsed the Manifesto from all over Europe and beyond. This shows a clear commitment and strong citizen engagement towards a better valorisation of research results, leaving no one behind.

Citizens who endorsed the Manifesto for EU COVID-19 Research explain their motivation to sign up and share their message to use research to benefit society.

Disclaimer: The views and opinions expressed in the videos are entirely those of the author(s) and do not reflect the official opinion of the European Commission. The clips have been filmed by individual volunteers. We have received more contributions than we could include. Many thanks to all contributors.

Early endorsers of the manifesto

Full list of signatories

Manifesto for EU COVID-19 research: full list of signatories
(6.46 MB - PDF)